FDA grants emergency use authorization for coronavirus saliva test

The FDA is granting emergency use authorization for a new, less invasive saliva test to detect coronavirus.
The NBA helped fund the development of the test because they use it to test for non-symptomatic carriers.
Health experts say it could help parts of the country where the infection rate continues to rise.
“It doesn't need the same re-agents and swabs that have been the limiting steps to create testing at scale in this country. It really could be a game changer if we can deploy it," says Dr. Abdul El Sayed, Epidemiologist.
Officials say results can be determined in under three hours.
Tests are expected to cost about $10 per sample.